Insulet Corp (PODD) Stock Price, Quote & News

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that...

Industry: Medical Devices

Sector: Healthcare

Phone: 978 600 7000

Website: www.insulet.com

Address:

100 Nagog Park, Acton, United States

peloswing Jul. 2 at 6:13 PM

$PODD just received the most serious type of recall from the FDA (Class I) for their Omnipods.... Anddd... the stock is up 4% and breaking downtrend 😂

2 · Reply

Brnxbmr Jul. 2 at 5:55 PM

$PODD MAJOR FDA RECALL.

1 · Reply

StreakGeek Jul. 2 at 5:42 PM

$PTC $MDT $ICE $PODD med

0 · Reply

passiontrader1 Jul. 2 at 4:25 PM

$PODD back to 250

0 · Reply

runitback349 Jul. 2 at 2:00 PM

$PODD took a starter 2k shares 160.50 average. Would like to add on pullback into the daily moving averages if it peters out

1 · Reply

runitback349 Jul. 1 at 11:40 PM

$PODD thing looks like it’s bottoming for a run into earnings. Watching for an entry

0 · Reply

passiontrader1 Jul. 1 at 7:12 PM

$PODD $250

1 · Reply

QuantInsider Jun. 30 at 4:55 PM

Big move on $PODD today A buyer swept 934 Dec $200 calls at the ask, dropping about $0.86M This is a serious upside bet with a six-month horizon PODD’s been up 3.4% over the last five days but today it’s down nearly 3% Interesting divergence since there’s only call flow, no puts Looks like bullish positioning We need some price stabilization to confirm this dip is bought and not the start of a reversal Keep an eye on how this plays out before jumping in on new shorts

0 · Reply

RocketTrader11 Jun. 30 at 2:42 PM

$PODD https://vistapglobal.com/needles-out-pumps-in-modulars-pivot-and-insulets-omnipod-seek-to-rewrite-the-diabetes-playbook-modd-podd/

0 · Reply

bulltrades1234 Jun. 30 at 1:51 PM

$PODD a little pump followed by a dump

1 · Reply

Grabar Law Office Investigates Claims on Behalf of Shareholders of Insulet Corporation (PODD)

2026-07-02T17:35:40.000Z - 2 days ago

FDA says Insulet recalled certain Omnipod Pods

Jul 1, 2026, 7:00 AM EDT - 3 days ago

Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026

Jun 30, 2026, 7:55 AM EDT - 4 days ago

20 stocks in the S&P 500 that plunged the most in 2026's first half

ACN ADBE BR BSX CRM CSGP CTSH

2026-06-25T11:05:30.000Z - 9 days ago

Insulet appoints Mazelsky to its Board of Directors

Jun 25, 2026, 7:00 AM EDT - 9 days ago

Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors

2026-06-23T16:57:56.000Z - 11 days ago

Insulet initiated with a Buy at Deutsche Bank

2026-06-23T13:18:30.000Z - 11 days ago

Insulet initiated with a Buy at Deutsche Bank

2026-06-11T17:35:58.000Z - 23 days ago

Insulet price target lowered to $219 from $250 at Truist

2026-06-08T19:25:55.000Z - 26 days ago

Insulet price target lowered to $216 from $263 at Raymond James

2026-06-07T21:55:05.000Z - 26 days ago

Insulet announces new results on tubeless AID systems

2026-06-04T18:35:28.000Z - 4 weeks ago

CDRH issues Early Alert about pump issue from Insulet

2026-06-04T11:08:57.000Z - 4 weeks ago

Insulet announces planned activities during ADA Scientific Sessions

Jun 4, 2026, 7:00 AM EDT - 4 weeks ago

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

Jun 3, 2026, 3:00 PM EDT - 4 weeks ago

Insulet Transcript: 46th Annual William Blair Growth Stock Conference

Jun 3, 2026, 3:00 PM EDT - 4 weeks ago

Insulet Slides: 46th Annual William Blair Growth Stock Conference

2026-06-03T11:35:31.000Z - 4 weeks ago

Insulet announces U.S. rollout of enhanced Omnipod 5 algorithm

Jun 3, 2026, 7:00 AM EDT - 4 weeks ago

Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor

2026-05-28T16:25:01.000Z - 5 weeks ago

Insulet court victory over EOFlow reversed on appeal

May 28, 2026, 10:34 AM EDT - 5 weeks ago

US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow

2026-05-28T12:17:04.000Z - 5 weeks ago

Insulet price target lowered to $165 from $175 at Citi

May 27, 2026, 4:05 PM EDT - 5 weeks ago

Insulet to Participate in William Blair 46th Annual Growth Stock Conference

2026-05-27T12:40:49.000Z - 5 weeks ago

Insulet price target lowered to $205 from $237 at Goldman Sachs

2026-05-26T23:10:09.000Z - 5 weeks ago

Insulet price target lowered to $235 from $260 at BTIG

May 26, 2026, 4:50 PM EDT - 5 weeks ago

Insulet flags dosing defect in some Omnipod devices, sees up to $50 million cost

2026-05-26T20:10:11.000Z - 5 weeks ago

Insulet initiates voluntary medical device correction for certain Omnipod lots

May 26, 2026, 4:05 PM EDT - 5 weeks ago

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets

May 20, 2026, 10:05 AM EDT - 6 weeks ago

These 15 S&P 500 stocks could be contrarian ways to play the market's uneven rally

APH APP AXON CSGP CVNA EL FICO

May 20, 2026, 8:00 AM EDT - 6 weeks ago

Insulet Transcript: AGM 2026

May 13, 2026, 12:20 PM EDT - 7 weeks ago

Insulet Transcript: Bank of America Global Healthcare Conference 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Insulet Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Insulet Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Insulet Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 2 months ago

Insulet Quarterly report: Q1 2026

May 6, 2026, 7:46 AM EDT - 2 months ago

Insulet lifts annual revenue forecast after quarterly beat on strong insulin pump demand

May 6, 2026, 7:00 AM EDT - 2 months ago

Insulet Reports First Quarter 2026 Results

May 6, 2026, 7:00 AM EDT - 2 months ago

Insulet Slides: Investor presentation

May 5, 2026, 7:00 AM EDT - 2 months ago

Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities

May 5, 2026, 7:00 AM EDT - 2 months ago

Insulet Slides: Omnipod® 5 competitive clinical performance presentation

May 4, 2026, 7:00 AM EDT - 2 months ago

Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes

Apr 28, 2026, 7:00 AM EDT - 2 months ago

Insulet to Participate in BofA Securities 2026 Health Care Conference

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Insulet Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Insulet Proxy statement: Proxy filing

Apr 1, 2026, 7:00 AM EDT - 3 months ago

Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026

Mar 30, 2026, 8:30 AM EDT - 3 months ago

Insulet Appoints Mike Panos as Chief Commercial Officer

Mar 12, 2026, 5:22 PM EDT - 4 months ago

Insulet recalls some insulin devices in US over leakage risk

Mar 12, 2026, 4:05 PM EDT - 4 months ago

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.

Mar 11, 2026, 4:01 PM EDT - 4 months ago

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes

Mar 10, 2026, 7:00 AM EDT - 4 months ago

Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Feb 18, 2026, 8:00 AM EST - 4 months ago

Insulet Earnings Call Transcript: Q4 2025

Feb 18, 2026, 8:00 AM EST - 4 months ago

Insulet Annual report: Q4 2025

Feb 18, 2026, 8:00 AM EST - 4 months ago

Insulet Earnings release: Q4 2025

Feb 18, 2026, 8:00 AM EST - 4 months ago

Insulet Slides: Q4 2025

Feb 18, 2026, 7:55 AM EST - 4 months ago

Insulet beats quarterly estimates on strong demand for wearable insulin pumps

Feb 18, 2026, 7:00 AM EST - 4 months ago

Insulet Reports Fourth Quarter and Full Year 2025 Results

Feb 18, 2026, 7:00 AM EST - 4 months ago

Insulet Slides: Investor presentation

Feb 5, 2026, 7:00 AM EST - 5 months ago

Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care

Jan 19, 2026, 12:41 PM EST - 5 months ago

Is PODD A Better Bet Than ISRG Stock?

ISRG

Jan 13, 2026, 2:15 PM EST - 6 months ago

Insulet Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 2:15 PM EST - 6 months ago

Insulet Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 9, 2026, 6:00 AM EST - 6 months ago

Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

Jan 6, 2026, 7:00 AM EST - 6 months ago

Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health

Dec 16, 2025, 7:00 AM EST - 7 months ago

Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference

Dec 15, 2025, 7:00 AM EST - 7 months ago

Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future

Dec 11, 2025, 10:37 AM EST - 7 months ago

Eight stock picks to play one of the healthiest corners of the market

ALNY ASND INSM MASI NTRA UNH WGS

Dec 4, 2025, 7:00 AM EST - 7 months ago

Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience

Nov 20, 2025, 12:30 PM EST - 8 months ago

Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day

Nov 20, 2025, 9:00 AM EST - 8 months ago

Insulet Transcript: Investor Day 2025

Nov 20, 2025, 9:00 AM EST - 8 months ago

Insulet Slides: FY 2025

Nov 12, 2025, 2:15 PM EST - 8 months ago

PODD Vs. Intuitive Surgical: This Underdog Might Just Win

ISRG

Nov 6, 2025, 8:00 AM EST - 8 months ago

Insulet Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 8 months ago

Insulet Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 8 months ago

Insulet Earnings release: Q3 2025

Nov 6, 2025, 8:00 AM EST - 8 months ago

Insulet Slides: Q3 2025

Nov 6, 2025, 7:29 AM EST - 8 months ago

Insulet tops quarterly estimates on demand for wearable insulin pumps

Nov 6, 2025, 6:30 AM EST - 8 months ago

Insulet Reports Third Quarter 2025 Results

Nov 4, 2025, 1:20 PM EST - 8 months ago

Final Trades: Insulet Corp, Uber and Apollo Global

APO UBER

Oct 30, 2025, 4:00 AM EDT - 8 months ago

Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month

Oct 23, 2025, 11:29 AM EDT - 9 months ago

10 stocks primed for growth in the S&P 500's cheapest sectors

BX AJG APO BRO DXCM FITB HOOD

Oct 23, 2025, 7:00 AM EDT - 9 months ago

Insulet Announces Appointment of Robert L. Huffines to its Board of Directors

Oct 10, 2025, 7:00 AM EDT - 9 months ago

Insulet to Host Investor Day on November 20, 2025

Sep 22, 2025, 10:19 AM EDT - 10 months ago

These 15 stocks have beaten the S&P 500 this year — while getting cheaper in the process

ADI BA CCL COIN DASH NUE NVDA

Sep 18, 2025, 7:00 AM EDT - 10 months ago

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

Sep 16, 2025, 7:25 AM EDT - 10 months ago

Medical device maker Insulet names industry veteran Flavia Pease as CFO

Sep 16, 2025, 7:00 AM EDT - 10 months ago

Insulet Announces CFO Transition

peloswing Jul. 2 at 6:13 PM

$PODD just received the most serious type of recall from the FDA (Class I) for their Omnipods.... Anddd... the stock is up 4% and breaking downtrend 😂

2 · Reply

Brnxbmr Jul. 2 at 5:55 PM

$PODD MAJOR FDA RECALL.

1 · Reply

StreakGeek Jul. 2 at 5:42 PM

$PTC $MDT $ICE $PODD med

0 · Reply

passiontrader1 Jul. 2 at 4:25 PM

$PODD back to 250

0 · Reply

runitback349 Jul. 2 at 2:00 PM

$PODD took a starter 2k shares 160.50 average. Would like to add on pullback into the daily moving averages if it peters out

1 · Reply

runitback349 Jul. 1 at 11:40 PM

$PODD thing looks like it’s bottoming for a run into earnings. Watching for an entry

0 · Reply

passiontrader1 Jul. 1 at 7:12 PM

$PODD $250

1 · Reply

QuantInsider Jun. 30 at 4:55 PM

0 · Reply

RocketTrader11 Jun. 30 at 2:42 PM

$PODD https://vistapglobal.com/needles-out-pumps-in-modulars-pivot-and-insulets-omnipod-seek-to-rewrite-the-diabetes-playbook-modd-podd/

0 · Reply

bulltrades1234 Jun. 30 at 1:51 PM

$PODD a little pump followed by a dump

1 · Reply

RocketTrader11 Jun. 29 at 4:55 PM

$PODD https://youtu.be/SaPywoFMBEg?si=fc7z4FTkMiGcwdka

1 · Reply

MODDBlueInMyBlood Jun. 29 at 2:59 PM

$MODD STOP DELETING MY POSTS, YOU SONS OF GUNS. $PODD $TNDM $MDT $ABT I ACTUALLY THINK MODD IS WORTH BEING AQUIRED THIS IS AN ACTUAL PREDICTION WTF IS YOUR PROBLEM DEBATE ME, OR GET OUT OF TOWN.

1 · Reply

PFM88 Jun. 26 at 1:37 PM

$PODD stop buying options… options will push this back down again🥲

1 · Reply

MODDBlueInMyBlood Jun. 24 at 2:23 PM

$MODD $PODD $TNDM $MDT WE GOTTA FIGHT HARD FOR THIS

1 · Reply

RocketTrader11 Jun. 24 at 1:55 PM

$PODD https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/modular-medical-announces-commercial-availability-of-pivot-tubeless-i-1180351

1 · Reply

UpgradeDowngrade Jun. 24 at 11:12 AM

$PODD Deutsche Bank has altered their rating of "Buy" and target of "$190" see consensus outlook

0 · Reply

MODDBlueInMyBlood Jun. 23 at 7:44 PM

$MODD $MDT $PODD $TNDM Screenshot me at your own peril. Holding through the storm 💎 Ill enjoy your screams of agony when the sp doubles

0 · Reply

theoptionsplug Jun. 23 at 1:54 PM

Top Performers in the S&P 500 so far today: $CDW $AXON $MRNA $PODD

2 · Reply

PFM88 Jun. 22 at 4:36 PM

$PODD new 52 low? It won’t move for a long time until options been cleared out🥲

1 · Reply

ssdsddssd2 Jun. 22 at 3:03 PM

$PODD when its 135 i buy 50s

0 · Reply

MODDBlueInMyBlood Jun. 22 at 12:56 PM

$MODD $PODD $MDT $TNDM FORGET ABOUT THEM. THIS IS OUR WEEK! JUST WAIT FOR HE DAY!

3 · Reply

BioTechHealthX Jun. 21 at 3:17 PM

$PODD Insulet Corporation (PODD) has a 67.59% upside estimate, a $10.18 billion market cap, and new Omnipod 6 data that could reshape the diabetes technology story investors are watching closely. https://biotechhealthx.com/biotech-news/could-insulet-corporation-podd-be-a-smart-long-term-buy-in-healthcare-innovation/

0 · Reply

Market Cap	11.39B
Revenue (ttm)	2.71B
Net Income (ttm)	247.10M
EPS (ttm)	N/A
PE Ratio	29.70
Forward PE	24.72
Profit Margin	9.12%
Debt to Equity Ratio	0.73

Volume	1,506,000
Avg Vol	1,663,296
Day's Range	N/A - N/A
Shares Out	69.27M
Stochastic %K	88%
Beta	1.11
Analysts	Strong Sell
Price Target	$232.40